Chun Luo Selected Research

Glioblastoma (Glioblastoma Multiforme)

7/2022	Prognosis and Immune Landscapes in Glioblastoma Based on Gene-Signature Related to Reactive-Oxygen-Species.
1/2021	Accurately Controlled Delivery of Temozolomide by Biocompatible UiO-66-NH2 Through Ultrasound to Enhance the Antitumor Efficacy and Attenuate the Toxicity for Treatment of Malignant Glioma.
4/2017	Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis.
1/2016	MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment.
6/2015	Downregulation of Id2 increases chemosensitivity of glioma.
1/2015	AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo.
1/2015	Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis.
3/2013	Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
8/2012	Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells.
2/2012	Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun Luo Research Topics

Disease

25	Glioma (Gliomas) 08/2022 - 04/2004
23	Neoplasms (Cancer) 01/2021 - 01/2006
10	Glioblastoma (Glioblastoma Multiforme) 07/2022 - 02/2012
3	Infections 04/2022 - 01/2018
3	Epilepsy (Aura) 12/2021 - 01/2015
3	Carcinogenesis 01/2018 - 02/2010
3	Fibrosis (Cirrhosis) 01/2018 - 09/2013
3	Brain Injuries (Brain Injury) 01/2017 - 10/2002
3	Astrocytoma (Pilocytic Astrocytoma) 05/2013 - 03/2008
2	Inflammation (Inflammations) 04/2022 - 01/2021
2	Reperfusion Injury 09/2021 - 01/2015
2	Lung Injury 01/2021 - 09/2011
2	Temporal Lobe Epilepsy 01/2020 - 01/2016
2	Cognitive Dysfunction 01/2020 - 01/2016
2	Wounds and Injuries (Trauma) 04/2019 - 09/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 09/2013
2	Alzheimer Disease (Alzheimer's Disease) 06/2016 - 01/2008
2	Meningioma (Meningiomas) 01/2015 - 01/2006
2	Congenital Abnormalities (Deformity) 07/2014 - 07/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 10/2013 - 08/2012
2	Torticollis (Wryneck) 10/2009 - 01/2009
2	Hypoxia (Hypoxemia) 11/2007 - 03/2003
1	Sepsis (Septicemia) 04/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Cerebral Infarction 09/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2021
1	COVID-19 01/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Colitis 01/2021
1	Chronic Hepatitis B 01/2019
1	Visceral Pain 09/2018
1	Genomic Instability 08/2018
1	Lung Neoplasms (Lung Cancer) 08/2018
1	Virus Diseases (Viral Diseases) 02/2018
1	Sclerosis 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 04/2022 - 06/2004
9	Small Interfering RNA (siRNA)IBA 01/2016 - 02/2012
8	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2009
5	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
5	DNA (Deoxyribonucleic Acid)IBA 08/2018 - 10/2009
5	Messenger RNA (mRNA)IBA 11/2013 - 10/2002
4	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2015
4	Complementary DNA (cDNA)IBA 01/2006 - 04/2004
3	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2017
3	Oxygen (Dioxygen)IBA 09/2021 - 01/2015
3	LuciferasesIBA 01/2021 - 02/2018
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2006
3	Biological ProductsIBA 01/2021 - 01/2006
3	salicylhydroxamic acid (SHAM)IBA 01/2016 - 09/2006
3	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2015 - 03/2013
2	Metal-Organic FrameworksIBA 08/2022 - 01/2021
2	Mitogen-Activated Protein KinasesIBA 04/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 03/2003
2	Therapeutic UsesIBA 01/2021 - 09/2013
2	Liposomes (Liposome)IBA 01/2018 - 09/2006
2	Pentylenetetrazole (Metrazol)IBA 01/2017 - 01/2016
2	Protein Kinases (Protein Kinase)IBA 01/2015 - 08/2012
2	Caspase 3 (Caspase-3)IBA 01/2015 - 01/2015
2	Teniposide (VM 26)FDA Link 08/2012 - 01/2009
2	Ubiquitin-Conjugating EnzymesIBA 02/2010 - 03/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2022
1	Hypnotics and Sedatives (Sedatives)IBA 04/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2021
1	CytokinesIBA 09/2021
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	Interleukin-27 (Interleukin 27)IBA 09/2021
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2021
1	Dextran SulfateIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	ferrostatin-1IBA 01/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020
1	Kainic Acid (Kainate)IBA 01/2020
1	Disks Large Homolog 4 ProteinIBA 01/2020
1	SynaptophysinIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	Interferon-alpha (Interferon Alfa)IBA 01/2019
1	Pain-FreeIBA 09/2018
1	Ropivacaine (Naropin)FDA LinkGeneric 09/2018
1	Sufentanil (Sufenta)FDA LinkGeneric 09/2018
1	Local AnestheticsIBA 09/2018
1	ADS J1IBA 02/2018

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
3	Therapeutics 01/2021 - 05/2013
3	Radiotherapy 02/2014 - 01/2009
2	Laminectomy 07/2014 - 07/2013
1	Nanospheres 08/2022
1	Artificial Respiration (Mechanical Ventilation) 04/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Photothermal Therapy 01/2020
1	Cesarean Section (Caesarean Section) 09/2018
1	Traction 09/2018
1	Epidural Anesthesia 09/2018